<http://schema.org/description>
"(AP) &amp;amp;#151; Johnson &amp;amp; Johnson has agreed to pay as much as $2.2 billion to resolve an investigation into its marketing of the anti-psychotic drug Risperdal, according to a published report."^^<http://www.w3.org/2001/XMLSchema#string>
<http://medicalxpress.com/news/2012-07-jj-22b-risperdal-settlement.html>